Search Results for keywords:"National Institutes of Health"

The National Institute on Drug Abuse is holding a closed meeting to review and evaluate grant applications related to preventing the use of electronic nicotine delivery systems (ENDS) among adolescents. This meeting will take place on March 10, 2021, from 9:00 a.m. to 6:00 p.m., and will be held virtually at the National Institutes of Health. The sessions will be closed to the public due to the sensitivity of the content, which includes confidential information and personal data. Yvonne Owens Ferguson, Ph.D., is the contact person for more information.

The National Institutes of Health announced a change to the meeting schedule of the Cancer Genetics Study Section. The meeting, originally set to start at 8:00 a.m. on February 22, 2021, will now start at 9:30 a.m., ending the next day at 5:00 p.m., but the location remains the same at Rockledge Drive, Bethesda, MD. This announcement was previously reported in the Federal Register on January 22, 2021, and the meeting remains closed to the public.

The National Institutes of Health (NIH) announced a series of closed meetings organized by the Center for Scientific Review to evaluate grant applications. These meetings will occur virtually, following federal laws to ensure privacy and confidentiality since they involve discussions on trade secrets and personal information. Meetings cover topics such as medical imaging, neurodegeneration, radiation biology, and the development of therapeutics for chemical threats. Each session spans a full day, with specific dates in early May 2025, and contact information for the scientific review officers is provided for interested parties.

The National Institute on Drug Abuse (NIDA) has announced two upcoming closed meetings. These meetings are not open to the public to protect confidential information and the privacy of individuals involved. One meeting is scheduled for May 5-6, 2025, and will focus on reviewing small business innovation research grant applications. The other is on May 5, 2025, specifically targeting time-sensitive drug abuse research grant applications. Both meetings will be held virtually.

The National Library of Medicine is holding a closed meeting on April 17, 2025, from 10:30 a.m. to 3:00 p.m. This meeting is part of a review and evaluation of grant applications and will be conducted virtually. The discussions will include confidential topics such as trade secrets and personal information, which is why the meeting will not be open to the public. Zoe E. Huang, the Chief Scientific Review Officer, will be the contact person for this event.

The Center for Scientific Review (CSR) of the National Institutes of Health (NIH) is conducting a series of virtual closed meetings to assess grant applications. These meetings, which will occur from March 31 to April 25, 2025, are focused on various scientific disciplines, including neuroscience, drug discovery, and infectious diseases. The meetings are closed to the public as they involve discussions on confidential information, such as trade secrets and personal details. More information about each committee and their respective contact persons is provided in the notice.

The Department of Health and Human Services (HHS), via the National Institutes of Health (NIH), has amended a regulation regarding clinical trials. This change updates the web address in the regulation concerning where to find information about submitting trial data to ClinicalTrials.gov. The new rule removes the old URL https://prsinfo.clinicaltrials.gov and replaces it with https://clinicaltrials.gov or a future site, modernizing and centralizing information access. This amendment is technical and does not add new requirements for affected parties.

The National Institutes of Health announced in the Federal Register that several meetings will be held to review grant applications. These meetings are organized by the National Institute of General Medical Sciences. The meetings will take place in April 2025 and will be held virtually. They will involve discussions that are closed to the public to protect confidential and private information.

The National Human Genome Research Institute, part of the National Institutes of Health, announced a closed meeting for the Special Emphasis Panel on Population Genomic Screening. Scheduled for April 30, 2025, from 9:30 a.m. to 6:00 p.m., the meeting aims to review and evaluate grant applications but will be closed to the public to protect confidential information and personal privacy. The meeting will take place via video and will involve discussions that could reveal sensitive commercial and personal information.

The National Institute of Allergy and Infectious Diseases has announced that a meeting will be held on February 5-6, 2025. The meeting will be closed to the public under federal law due to discussions of confidential topics and personal information. The focus of the meeting will be to review and evaluate grant applications related to microbiology, infectious diseases, and AIDS. This video-assisted meeting will take place at the National Institutes of Health in Rockville, Maryland.